Ng, D.; Altamirano-Vallejo, J.C.; Navarro-Partida, J.; Sanchez-Aguilar, O.E.; Inzunza, A.; Valdez-Garcia, J.E.; Gonzalez-de-la-Rosa, A.; Bustamante-Arias, A.; Armendariz-Borunda, J.; Santos, A.
Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin. Pharmaceuticals 2024, 17, 175.
https://doi.org/10.3390/ph17020175
AMA Style
Ng D, Altamirano-Vallejo JC, Navarro-Partida J, Sanchez-Aguilar OE, Inzunza A, Valdez-Garcia JE, Gonzalez-de-la-Rosa A, Bustamante-Arias A, Armendariz-Borunda J, Santos A.
Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin. Pharmaceuticals. 2024; 17(2):175.
https://doi.org/10.3390/ph17020175
Chicago/Turabian Style
Ng, Dalia, Juan Carlos Altamirano-Vallejo, Jose Navarro-Partida, Oscar Eduardo Sanchez-Aguilar, Andres Inzunza, Jorge Eugenio Valdez-Garcia, Alejandro Gonzalez-de-la-Rosa, Andres Bustamante-Arias, Juan Armendariz-Borunda, and Arturo Santos.
2024. "Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin" Pharmaceuticals 17, no. 2: 175.
https://doi.org/10.3390/ph17020175
APA Style
Ng, D., Altamirano-Vallejo, J. C., Navarro-Partida, J., Sanchez-Aguilar, O. E., Inzunza, A., Valdez-Garcia, J. E., Gonzalez-de-la-Rosa, A., Bustamante-Arias, A., Armendariz-Borunda, J., & Santos, A.
(2024). Enhancing Ocular Surface in Dry Eye Disease Patients: A Clinical Evaluation of a Topical Formulation Containing Sesquiterpene Lactone Helenalin. Pharmaceuticals, 17(2), 175.
https://doi.org/10.3390/ph17020175